City
Epaper

Individual's immune response to Covid virus may determine vax efficacy

By IANS | Updated: November 13, 2023 18:45 IST

Tokyo, Nov 13 Researchers have found that individual immune responses to the SARS-CoV-2 virus, particularly in mutant strains, ...

Open in App

Tokyo, Nov 13 Researchers have found that individual immune responses to the SARS-CoV-2 virus, particularly in mutant strains, can influence the efficacy of Covid-19 vaccines.

Efforts to contain the Covid-19 pandemic have largely focused on vaccine development and deployment.

But how exactly do our immune systems respond to Covid-19 vaccines?

The major response occurs in one of two ways: the production of antibodies that bind to the receptor-binding domain (RBD) or the production of antibodies that bind to the N-terminal domain (NTD) of the coronavirus viral spike protein.

Both play important roles in preventing infection, pathogenesis, and severe disease.

However, the antibody repertoire varies widely among individuals.

While it has been suggested that this diversity in antibodies influences the ability to protect against mutant strains, its full extent has not been clear.

A team led by Osaka Metropolitan University researchers gained insight into the role of antibodies produced by vaccination in preventing infections, particularly in mutant strains of the coronavirus.

"The results of this study have demonstrated that understanding the nuances of antibody response to vaccination is critical for vaccine development," said Mayo Yasugi, an Associate Professor at the Graduate School of Veterinary Science at Osaka.

"We believe our findings will provide a foundation for improved vaccine development in the future," Yasugi added. The study, published in the journal Vaccine, focused on blood samples taken from volunteers 17 to 28 days post-2nd vaccination, a crucial period when antibody production peaks.

Furthermore, the study found that antibodies that primarily target NTD have a lower ability to protect against a delta variant of the coronavirus compared to those primarily targeting RBD.

Interestingly, the study also found that the presence or absence of infectivity-enhancing antibodies did not affect the ability of the antibodies to protect against variants.

Disclaimer: This post has been auto-published from an agency feed without any modifications to the text and has not been reviewed by an editor

Open in App

Related Stories

TechnologyCannabis use may spike risk of diabetes by 4-fold: Study

TechnologyIndia's smartphone exports surpass Rs 1 lakh crore this fiscal so far, Apple leads: Data

HealthCannabis use may spike risk of diabetes by 4-fold: Study

BusinessIndia's smartphone exports surpass Rs 1 lakh crore this fiscal so far, Apple leads: Data

TechnologyEngineer’s Day: ’Adani Cement FutureX’ programme launched to prepare future innovators

International Realted Stories

InternationalFive Eyes alliance must work together to counter Khalistani extremism: Report

International"Condition not back to normal pace, sales adversely affected"; Kathmandu locals after protests

InternationalINS Kadmatt's goodwill visit bolsters maritime security partnership between India, Fiji

InternationalB'desh: BNP, Jamaat at loggerheads over democracy and religious freedom

InternationalSouth Korea proposes bilateral currency swap with US in trade talks